Closure of the company’s factory in Leiden has been prevented, partly due to a loan from the cabinet.
The Apotex drug factory in Leiden, threatened with closure, will stay open under new ownership. This is partly possible because the cabinet is making a loan of € 6.7 million available. A principal agreement has been signed with the new owners, as State Secretary of Economic Affairs Mona Keijzer wrote in a letter to the Lower House on Thursday.
According to the government, preservation of the factory is important to better guarantee the availability of medicines in the Netherlands. The House of Representatives previously insisted on maintaining production capacity in the Netherlands. Certainly after the outbreak of the corona pandemic, there are fears that imports of medicines from countries outside Europe could be endangered.